Open AccessA double-blind, dose-response study of losartan in hypertensive children
Author(s) -
S. Shahinfar,
F. Cano,
Beth A. Soffer,
Tanveer Ahmed,
E Santoro,
Z ZHANG,
GW Gleim,
Karl Miller,
Bruno Vogt,
J Blumer
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2004.09.009
Subject(s) - medicine , losartan , double blind , blood pressure , cardiology , pharmacology , angiotensin ii , placebo , pathology , alternative medicine
The aim of this study was to determine the dose-response relationship for losartan, 2.5 to 100 mg, and to assess the safety and tolerability of losartan in hypertensive children 6 to 16 years of age.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom